Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / MSGE - Hot Stocks: PFE/BNTX COVID vaccine; EDIT rises on gene-editing data; MSGE revenue beat

MSGE - Hot Stocks: PFE/BNTX COVID vaccine; EDIT rises on gene-editing data; MSGE revenue beat

Madison Square Garden Entertainment Corp. Class A
Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) took the spotlight in Monday's midday trading on news that U.S. authorities had given full approval to their COVID-19 vaccine. Both stocks rose on the news. Drug development headlines also gave a boost to Axsome Therapeutics (NASDAQ:AXSM). Regulators have not requested any additional information about the company's application for a depression treatment. Elsewhere in the biotech space, Editas Medicine (NASDAQ:EDIT) rallied after it presented data on gene-editing technology. Meanwhile, Madison Square Garden Entertainment (NYSE:MSGE) posted a double-digit percentage gain in intraday action thanks to a dramatic revenue beat. The U.S. Food and Drug Administration announced that it has granted full approval to the COVID vaccine created by Pfizer (PFE) and BioNTech (BNTX) for people 16 years old and above. Previously, the product had been used under an emergency approval. The full approval could open the door to increased vaccine mandates. Meanwhile, the shot can still

For further details see:

Hot Stocks: PFE/BNTX COVID vaccine; EDIT rises on gene-editing data; MSGE revenue beat
Stock Information
Company Name: Madison Square Garden Entertainment Corp. Class A
Stock Symbol: MSGE
Market: NYSE
Website: www.msgentertainment.com
Menu
MSGE MSGE Quote MSGE Short MSGE News MSGE Articles MSGE Message Board
Get MSGE Alerts

News, Short Squeeze, Breakout and More Instantly...